Northwestern Mutual Wealth Management
ITRM

Northwestern Mutual Wealth Management’s Iterum Therapeutics ITRM Stock Holding History

Northwestern Mutual Wealth Management’s Portfolio ITRM Stock Details ITRM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-133
Closed -$133 – 3471
2023
Q1 		$133 Buy
+133
New +$153 ﹤0.01% 3225
2022
Q2 		– Sell
-26
Closed – – 3316
2022
Q1 		$0 Buy
+26
New +$150 ﹤0.01% 3248

Other funds holding ITRM

SM
Sabby Management Miami Beach, Florida $111M AUM 74.4% 1-Year Est. Return
AWM
Apollon Wealth Management Mount Pleasant, South Carolina $8.23B AUM 30.88% 1-Year Est. Return
NLVP
New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
KFS
Kelly Financial Services Braintree, Massachusetts $467M AUM 21.13% 1-Year Est. Return
NA
NewEdge Advisors New Orleans, Louisiana $33.6B AUM 31.03% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
CCMW
Cypress Capital Management (Wyoming) Sheridan, Wyoming $120M AUM 63.01% 1-Year Est. Return

Northwestern Mutual Wealth Management's ITRM Position: Q2 2023 in Review

Northwestern Mutual Wealth Management sold out of Iterum Therapeutics (ITRM) in Q2 2023, closing a stake of 133 shares — an estimated $133 sold.

Northwestern Mutual Wealth Management first reported a position in ITRM in Q1 2022 and held it in 2 quarters. The position peaked at $133 in Q1 2023. 17 funds tracked by Wall St. Rank hold ITRM as of Q2 2023.

  • Northwestern Mutual Wealth Management reported no remaining Iterum Therapeutics position as of Q2 2023 after selling out during the quarter.
  • Northwestern Mutual Wealth Management sold 133 Iterum Therapeutics shares in Q2 2023, an estimated $133.
  • Northwestern Mutual Wealth Management first reported a position in Iterum Therapeutics in Q1 2022 and held it in 2 quarters.
  • Northwestern Mutual Wealth Management's Iterum Therapeutics position peaked at $133 in Q1 2023.
  • 17 funds tracked by Wall St. Rank held Iterum Therapeutics as of Q2 2023.

Based on Northwestern Mutual Wealth Management's 13F filing for Q2 2023, filed 14 Aug 2023.